Back to Qube Research & Technologies Ltd Qube Research & Technologies Ltd

RLMDRLMD
9 quarters

Position history for Qube Research & Technologies LtdQube Research & Technologies Ltd's holdings in RELMADA THERAPEUTICS INC

Qube Research & Technologies Ltd holds 691,545 shares of RLMD (RELMADA THERAPEUTICS INC), worth $4.8M as of 2026-Q2. The position was increased (+5.8% shares). RLMD represents 0.0% of Qube Research & Technologies Ltd's portfolio.

Current Value

$4.8M

Current Shares

691,545

Total Value Change

+$4.7M

Total Shares Change

+646,016

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
691,545
+5.8%
$4.8M0.0%$6.92
29
2026-Q1
Increased
653,333
+320.1%
$4.5M0.0%$4.67
43
2025-Q4
New
155,529
-
$751,2050.0%$4.53
34
2024-Q3
Exited
0
-100.0%
$00.0%$3.37
0
2024-Q2
Decreased
56
-99.9%
$1680.0%$3.00
0
2024-Q1
Increased
72,979
+1367.2%
$339,3520.0%$4.65
38
2023-Q4
Increased
4,974
+29.6%
$20,5920.0%$4.14
16
2023-Q3
Decreased
3,838
-91.6%
$11,5140.0%$3.00
0
2023-Q2
New
45,529
-
$112,0010.0%$2.49
30

Other major holders of RLMD: RTW INVESTMENTS, LP, Janus Henderson Group Ltd., RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used